GridAI Technologies GRDX
NASDAQ GRDX
$2.95 -0.07 (-2.16%)
As of: Sep 10, 2026 · 3:09 PM EDT

GridAI Technologies (GRDX) Research & Development (2015 - 2026)

GridAI Technologies' (GRDX) quarterly Research & Development came in at $8424.0 in Q2 2026, down 20.76% on a YoY basis from $10631.0 in Q2 2025, and down 99.06% quarter-over-quarter from $895673.0 in Q4 2025.

Analysis

GridAI Technologies (GRDX) Research & Development (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Research & Development for 12 consecutive years, with $8424.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Research & Development fell 20.76% year-over-year to $8424.0; the trailing twelve-month figure through Jun 2026 stood at $921401.0 (up 261.51% YoY), and the FY2025 full-year result was $927753.0, up 2.63% from the prior year.
  • Research & Development fell to $8424.0 in Q2 2026 per GRDX's latest filing, from $895673.0 in the prior quarter.
  • Across five years, Research & Development topped out at $5.0 million in Q1 2022 and bottomed at $6673.0 in Q3 2025.
  • Historically, Research & Development has averaged $926436.4 across 5 years, with a median of $554662.0 in 2024.
  • The sharpest annual moves came in 2024 and 2025: Research & Development plunged 98.36% in 2024, then surged 4081.68% in 2025.
  • Over 5 years, Research & Development stood at $101822.0 in 2022, then surged by 1183.99% to $1.3 million in 2023, then slumped by 98.36% to $21419.0 in 2024, then soared by 4081.68% to $895673.0 in 2025, then plunged by 99.06% to $8424.0 in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $8424.0, $895673.0, and $6673.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Amgen 206.74 Bn 192.75 Bn 7.24 Bn 1.87 Bn
2 Gilead Sciences 179.96 Bn 176.78 Bn 6.22 Bn 1.76 Bn
3 Vertex Pharmaceuticals 131.20 Bn 123.35 Bn 2.84 Bn 993.80 Mn
4 Regeneron Pharmaceuticals 82.05 Bn 74.05 Bn 3.93 Bn 1.63 Bn
5 Argenx Se 60.28 Bn 55.10 Bn 1.37 Bn -486.00 Mn
6 Moderna 53.67 Bn 48.54 Bn 52.00 Mn 651.00 Mn
7 Alnylam Pharmaceuticals 33.08 Bn 29.78 Bn 992.69 Mn 413.13 Mn
8 Biogen 31.91 Bn 30.62 Bn 1.96 Bn 529.60 Mn
9 Roivant Sciences 29.22 Bn 29.22 Bn 1.16 Mn 202.02 Mn
10 GridAI Technologies 18.97 Mn 18.97 Mn -36,514.00 8,424.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8,424.00
Dec 31, 2025 895,673.00
Sep 30, 2025 6,673.00
Jun 30, 2025 10,631.00
Mar 31, 2025 15,827.00
Dec 31, 2024 21,419.00
Sep 30, 2024 206,999.00
Jun 30, 2024 219,591.00
Mar 31, 2024 554,662.00
Dec 31, 2023 1.31 Mn
Sep 30, 2023 1.01 Mn
Jun 30, 2023 1.35 Mn
Mar 31, 2023 1.36 Mn
Dec 31, 2022 101,822.00
Sep 30, 2022 791,067.00
Jun 30, 2022 2.91 Mn
Mar 31, 2022 4.98 Mn
Dec 31, 2021 5.78 Mn
Sep 30, 2021 3.05 Mn
Jun 30, 2021 5.65 Mn